Arrakis Bio

Private

IsraelHealthcare & Life Scienceshttps://www.arrakis.bio/

Last Round

Seed

Jul 19, 2023

Company Overview

Arrakis Bio is a biotechnology company that develops animal-free, high-quality human collagen and gelatin for medical, aesthetic, and biomedical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

RNA-targeted small moleculerSMdrug discoverybiotechnologyRNA therapeuticssmall molecule drugsundruggable targetsdrug discovery platformbiopharmaRNA structuremedicinal chemistryAI-augmented drug discoverycomputational biologydrug development partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arrakis Bio Comps

Public and private peers based on sector, stage, and business model.

Arrakis Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arrakis Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 19, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Dalia Rosin

CTO And Co-founder

Founding Team

Fabian Trumper

Co-Founder CEO

Founding Team

Arrakis Bio Investors

Notable investors and investment history

Arrakis Bio investors
Investor	Rounds
FLORA Ventures	Seed

View all Investors

Arrakis Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Arrakis Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arrakis Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael

Employee Range5

Year Founded2023

Last FundingJul 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.